
PRES Congress
33rd European Paediatric Rheumatology Congress, Belgrade, Serbia. 16-19th Sept
View details
UKIVas advances research, strengthens clinical understanding, and supports better outcomes for those affected by vasculitis.
A summary of the core areas of the work including active research, clinical collaboration and educational opportunities for those seeking to engage with UKIVas.
To unite and educate the professional community to improve the outcomes for patients of all ages living with vasculitis.
To provide professionals working in the field of vasculitis with a rich source of data acquired through large scale collaborative working.
To facilitate best practice and a positive environment that aids communication for this collection of rare diseases.

UKIVas brings together leading clinicians, researchers, and partners to advance the understanding, diagnosis, and management of vasculitis. Through collaboration and shared expertise, we support progress that improves outcomes for patients across the UK.
UKIVAS events bring together clinicians, researchers, and collaborators to share knowledge and discuss advances in vasculitis care. These include educational courses, meetings, and conferences. Browse the events below to find out more and access further details.

33rd European Paediatric Rheumatology Congress, Belgrade, Serbia. 16-19th Sept
View details
A three-day educational course covering vasculitis research, diagnosis and management.
View details
@ukivas.bsky.social

Interested in Vasculitis?
We are new to Bluesky, please follow
@ukivas.bsky.social

From RAIRDA
🔎 In the UK we are looking at what NHS support is needed by people with #Sjögren’s, #Lupus, #Myositis #Vasculitis #Behçet’s & #Scleroderma please complete this survey
đź“‹ www.tinyurl.com/RAISE2025
Guidelines update AAV – treatment – Dimitrios Chanouzas

Vasculitis UK supports patients of all ages living with all forms of vasculitis, providing trusted information, a listening ear, and a community.

In February 2025, 53 experts from 13 countries convened at Alder Hey Children's NHS Foundation Trust in Liverpool for a multiprofessional international workshop focused on building a pathway to high-quality clinical trials in IgAV-N.

On 5th June 2026, the MHRA announced a review of the benefits and risks of avacopan in ANCA-associated vasculitis (AAV)
Discover further opportunities to support UKIVas, join research initiatives, contribute expertise, or engage with our community.
Get in touch with our team for enquiries, collaboration opportunities, or support accessing information related to vasculitis research.